A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.
Looking for a particular Celltrion Inc. employee's phone or email?
The Celltrion Inc. annual revenue was $2 billion in 2026.
Sang Lee is the President of Celltrion Inc..
1,099 people are employed at Celltrion Inc..
Celltrion Inc. is based in Incheon, Gyeonggi.
The NAICS codes for Celltrion Inc. are [3254, 32541, 32, 325, 325414].
The SIC codes for Celltrion Inc. are [283, 28].